Skip to main content
. 2014 Dec 15;5(1):243–254.

Table 3.

The expression of tumor-associated indices/factors (n = 12)

Groups CRP (µg/mL) IL-2 (ng/mL) VEGF (pg/mL) IL-6 (ng/mL) TNF-α (ng/mL)
Blank wafer 1893.54 ± 172.42 1008.81 ± 105.77 1068.44 ± 247.05 147.39 ± 6.27 276.64 ± 38.21
ADS-I wafer (0.77 mg) 1634.32 ± 293.49* 1150.56 ± 214.65* 877.66 ± 151.05 100.93 ± 20.37 218.08 ± 39.80*
ADS-I wafer (1.53 mg) 1525.44 ± 267.16** 1193.64 ± 102.89* 765.53 ± 149.86* 89.40 ± 21.69* 211.26 ± 31.44*
ADS-I solution 1886.08 ± 131.52 1112.59 ± 130.4 902.00 ± 127.35 132.82 ± 26.20* 227.59 ± 47.34

The plasma levels of these tumor-associated factors were determined using ELISA kits. Statistical significant as compared to blank wafer group was determined by ANOVA.

*

p < 0.05;

**

p < 0.01.